Rallybio Corp. (RLYB)
16.81
+0.05
(+0.30%)
USD |
NASDAQ |
Aug 28, 16:00
16.84
+0.03
(+0.18%)
After-Hours: 20:00
Rallybio Free Cash Flow : 26.71M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.71M |
| March 31, 2026 | -27.59M |
| December 31, 2025 | -29.81M |
| September 30, 2025 | -35.00M |
| June 30, 2025 | -41.99M |
| March 31, 2025 | -44.03M |
| December 31, 2024 | -49.28M |
| September 30, 2024 | -51.08M |
| June 30, 2024 | -54.00M |
| March 31, 2024 | -56.97M |
| December 31, 2023 | -60.28M |
| September 30, 2023 | -63.88M |
| Date | Value |
|---|---|
| June 30, 2023 | -62.15M |
| March 31, 2023 | -62.34M |
| December 31, 2022 | -57.34M |
| September 30, 2022 | -52.10M |
| June 30, 2022 | -48.36M |
| March 31, 2022 | -47.64M |
| December 31, 2021 | -45.87M |
| September 30, 2021 | -43.21M |
| June 30, 2021 | -37.85M |
| March 31, 2021 | -28.63M |
| December 31, 2020 | -22.18M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Q32 Bio, Inc. | -19.83M |
| Beam Therapeutics, Inc. | -372.77M |
| C4 Therapeutics, Inc. | -85.39M |
| Cullinan Therapeutics, Inc. | -159.26M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |